⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 1, 2006Retina

Six-Month Stability of Bevacizumab (Avastin) Binding to Vascular Endothelial Growth Factor After Withdrawal Into a Syringe and Refrigeration or Freezing

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

The anti-VEGF activity of bevacizumab may degrade minimally over time, with storage.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bakri et al. (2006) studied this question.

synapsesocial.com/papers/69deb7b1c3a6346e97e93a83 https://doi.org/10.1097/01.iae.0000225354.92444.7a

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

1Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular DegenerationCost-Effectiveness Analysis · 2005 · 907 citations
2Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein OcclusionOriginal Research · 2005 · 489 citations
3REGRESSION OF RETINAL AND IRIS NEOVASCULARIZATION AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENTReview · 2006 · 342 citations